Research Article
Open Access
BACE2 distribution in major brain cell types and identification of novel substrates
Iryna Voytyuk, Stephan A Mueller, Julia Herber, An Snellinx, Dieder Moechars, View ORCID ProfileGeert van Loo, Stefan F Lichtenthaler, View ORCID ProfileBart De Strooper Correspondence email
Iryna Voytyuk
1Department of Neurosciences, Katholieke Universiteit Leuven, Leuven, Belgium
2Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium
Stephan A Mueller
3German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
4Neuroproteomics, School of Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
Julia Herber
3German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
4Neuroproteomics, School of Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
An Snellinx
1Department of Neurosciences, Katholieke Universiteit Leuven, Leuven, Belgium
2Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium
Dieder Moechars
5Discovery Neuroscience, Janssen Research and Development, Division of Janssen Pharmaceutica NV, Beerse, Belgium
Geert van Loo
6Center for Inflammation Research, VIB, Gent, Belgium
7Department of Biomedical Molecular Biology, Gent University, Gent, Belgium
Stefan F Lichtenthaler
3German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
4Neuroproteomics, School of Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
8Institute for Advanced Study, Technische Universität München, Munich, Germany
9Munich Cluster for Systems Neurology, Munich, Germany
Bart De Strooper
1Department of Neurosciences, Katholieke Universiteit Leuven, Leuven, Belgium
2Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium
9Munich Cluster for Systems Neurology, Munich, Germany
10Dementia Research Institute, Institute of Neurology, University College London, London, UK
Published 15 February 2018. DOI: 10.26508/lsa.201800026
BACE2 brain expression and substrates
Iryna Voytyuk, Stephan A Mueller, Julia Herber, An Snellinx, Dieder Moechars, Geert van Loo, Stefan F Lichtenthaler, Bart De Strooper
Life Science Alliance Feb 2018, 1 (1) e201800026; DOI: 10.26508/lsa.201800026
In this Issue
Volume 1, No. 1
January 2018
Advertisement
Jump to section
Subjects
Related Articles
- No related articles found.
Cited By...
- A single-cell eQTL atlas of the human cerebellum reveals vulnerability of oligodendrocytes in essential tremor
- Therapeutic Potential of Targeting Regulated Intramembrane Proteolysis Mechanisms of Voltage-Gated Ion Channel Subunits and Cell Adhesion Molecules
- Genetic Mapping of APP and Amyloid-{beta} Biology Modulation by Trisomy 21
- Genetic mapping of APP and amyloid-{beta} biology modulation by trisomy 21
- Endosomal structure and APP biology are not altered in preclinical cellular models of Down syndrome
- Epigenetic profiling of Italian patients identified methylation sites associated with hereditary Transthyretin amyloidosis
- Gga3 deletion and a GGA3 rare variant associated with late onset Alzheimers disease trigger BACE1 accumulation in axonal swellings
- Quantitative secretome analysis establishes the cell type-resolved mouse brain secretome
- AAV mediated delivery of a novel anti-BACE1 VHH reduces Abeta in an Alzheimers disease mouse model
- A promising, novel, and unique BACE1 inhibitor emerges in the quest to prevent Alzheimer's disease